Evolocumab use and LDL-C lowering in a cohort of European patients with familial hypercholesterolemia (FH) - results from the Heymans study. (August 2021) - Sibartie, M.; Dhalwani, N.; Ebenbichler, C.; Filardi, P. Perrone; Bruckert, E.